Seelos Therapeutics Inc (NASDAQ:SEEL)
| 1.18 Delayed Data As of Jan 21 |  -0.07 / -5.60%Today’s Change | 1.15 Today|||52-Week Range 6.60 | -27.61% Year-to-Date |
Latest SEEL News | Press Releases
No recent news for Seelos Therapeutics Inc.
Today’s Trading
| Previous close | 1.25 |
| Today’s open | 1.24 |
| Day’s range | 1.16 - 1.24 |
| Volume | 130,912 |
| Average volume (3 months) | 3,612,461 |
| Market cap | $120.8M |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | +83.09% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 25.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRTGPortage Biotech Inc | -0.57 | -6.10% |
| AQBAquaBounty Technolog... | -0.09 | -5.14% |
| --Wang On Group Ltd | 0.00 | 0.00% |
| LJPCLa Jolla Pharmaceuti... | -0.01 | -0.22% |
Data as of 4:00pm ET, 01/21/2022
Financials
| Next reporting date | March 4, 2022 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$19.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
